Human Papilloma Virus (HPV).

Most HPV infections cause no symptoms and resolve spontaneously; however if HPV infection persists, it can cause pre-cancerous lesions and increase the risk of cancer of the cervix, vulva, vagina, prostate, anus, mouth and/or throat. Recent clinical trials in Phase 1 has shown the real potential of artemisinin to treat both HPV-related cervical and anal intraepithelial neoplasia.

Cytomegalovirus infection.

Cytomegalovirus (CMV) is a common virus that can infect almost anyone. Once infected, the body retains the virus for life. Most people don’t know they have CMV because it rarely causes problems in healthy people. CMV is spread through close contact with bodily fluids. Most people with CMV don’t get sick and don’t know that they’ve been infected. But infection with the virus can be serious in babies and people with weak immune systems. Completed Phase 3 clinical trials have shown that, primarily, artemisinin and artesunate have high potential to treat these viral infections.

References: